+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Dermatology Drugs Market by Therapeutic Class (Antifungals, Corticosteroids, Immunosuppressants), Route of Administration (Oral, Parenteral Injection, Topical), Indication Type, End-User, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967940
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dermatology Drugs Market grew from USD 31.40 billion in 2023 to USD 34.23 billion in 2024. It is expected to continue growing at a CAGR of 9.83%, reaching USD 60.56 billion by 2030.

This category includes medications designed to treat a vast range of dermatological conditions such as acne, dermatitis, psoriasis, skin infections, and skin cancers, among others. Dermatology drugs may come in various forms, including topical applications, oral medications, injections, and infusions, tailored to address specific conditions effectively. The selection of a dermatology drug involves considerations of the condition's severity, the patient's medical history, and the drug's mechanism of action. An increasing elderly population is more prone to skin diseases, and The rising number of individuals suffering from skin diseases globally fuels the demand for dermatology drugs. Further, innovations in drug delivery systems and formulation technology enhance the efficacy and convenience of dermatology drugs. Growing cultural acceptance and economic ability to undergo cosmetic treatments have boosted the demand for aesthetic dermatology drugs. However, the high cost associated with new and innovative dermatology drugs can limit the market growth. Safety concerns and side effects associated with dermatology drugs can lead to decreased patient compliance and usage. Nevertheless, exploring areas such as personalized medicine, which tailors treatment to individual genetic makeup, and the development of minimally invasive treatment options holds significant promise for business growth. Furthermore, investing in the research of natural and organic dermatological products can meet the increasing consumer demand for sustainable and side-effect-free options. Expanding telemedicine services for dermatology can also provide a competitive edge by enhancing patient access and convenience.

Regional Insights

In America, the United States dominates the dermatology drugs market due to its robust healthcare infrastructure, high healthcare spending, and presence of leading pharmaceutical companies. The market is characterized by high demand for biologics and novel therapies for treating severe skin conditions, such as psoriasis and atopic dermatitis. Regulatory support from the FDA for fast-track approvals has also been a key driver. The EMEA region presents a diverse landscape for dermatology drugs, with Western Europe being the most developed market. Regulatory frameworks here are stringent, with the EMA overseeing drug approvals. Increased R&D investments and favorable reimbursement policies are driving the market in Europe. Despite having a smaller market share, the Middle East and Africa are experiencing growth due to rising awareness and improving healthcare infrastructure. The Asia Pacific region shows a growing landscape for dermatology drugs, driven by rapid urbanization, increasing disposable incomes, and a large patient pool. Countries including China and India are at the forefront, with governments implementing favorable policies to attract foreign investment in healthcare. The prevalence of generic drugs is high in this region, providing cost-effective treatment options.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Dermatology Drugs Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing prevalence of skin diseases such as psoriasis, eczema, acne, and skin cancer
  • Technological advancements in drug development, along with a strong pipeline of dermatological drugs
  • Increasing adoption of biologics for treatment-resistant conditions among geriatric condition

Market Restraints

  • Stringent and time-consuming regulatory approval process

Market Opportunities

  • Emerging investment in personalized medicine, and rising application in telemedicine
  • Notable shift towards natural and organic ingredients in dermatological products

Market Challenges

  • High treatment costs and stringent regulatory policy

Market Segmentation Analysis

  • Therapeutic Class: Proliferation of immunosuppressants in dermatology for the treatment of severe or refractory skin conditions
  • End-User: High inclination towards aesthetic and dermatology clinics owing to increasing societal emphasis on appearance and wellness

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dermatology Drugs Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dermatology Drugs Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Almirall and Microsoft announce partnership for the development of novel treatments for skin diseases

Almirall S.A. has collaborated with Microsoft to spearhead innovation and propel its digital transformation agenda. This three-year collaboration is poised to revolutionize dermatological drug development. The partnership aims to harness generative A.I. and advanced analytics to accelerate the discovery and development of new treatment options, integrating Almirall's comprehensive R&D proficiency with Microsoft's state-of-the-art digital technology. This collaboration underscores the development of cutting-edge dermatological solutions that meet patient needs.

FDA Approves Arcutis’ ZORYVE (roflumilast) Topical Foam, 0.3% for the Treatment of Seborrheic Dermatitis

Arcutis Biotherapeutics, Inc. received U.S. FDA approval for ZORYVE (roflumilast) topical foam, 0.3% for treating seborrheic dermatitis for individuals aged nine and above. This topical treatment promises to revolutionize the management of seborrheic dermatitis, offering an easy and effective solution that caters to difficult-to-treat areas without the limitations commonly associated with long-term use.

Eli Lilly forays into dermatological space with launch of psoriasis drug

Eli Lilly has made entry into the dermatological sector in India with the introduction of Copellor, a pioneering treatment for individuals suffering from moderate-to-severe plaque psoriasis. Copellor has been approved by the Drug Controller General of India (DCGI), represents a novel approach by targeting a specific protein responsible for the inflammation associated with psoriasis. This launch marks Eli Lilly's expansion into a new therapeutic area and emphasizes the delivery of innovative healthcare solutions.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dermatology Drugs Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Dermatology Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergan plc by Abbvie Inc., Almirall S.A., Amgen Inc., Arcutis Biotherapeutics, Inc., Asterisk Laboratories, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Cipla Limited, Concert Pharmaceuticals by Sun Pharmaceutical Industries Limited, DermBiont, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Galderma S.A., GlaxoSmithkline plc, Johnson & Johnson Services, Inc., Leo Pharma A/S, Lupin Ltd, Mayne Pharma Group Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc., Roivant Sciences Ltd., and Shinom Cosmeceuticals.

Market Segmentation & Coverage

This research report categorizes the Dermatology Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapeutic Class

  • Antifungals
  • Corticosteroids
  • Immunosuppressants
  • Retinoids

Route of Administration

  • Oral
  • Parenteral Injection
  • Topical

Indication Type

  • Acne
  • Atopic dermatitis
  • Psoriasis
  • Skin cancer

End-User

  • Aesthetic & Dermatology Clinics
  • Diagnostic Centers & Laboratories
  • Hospitals

Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of skin diseases such as psoriasis, eczema, acne, and skin cancer
5.1.1.2. Technological advancements in drug development, along with a strong pipeline of dermatological drugs
5.1.1.3. Increasing adoption of biologics for treatment-resistant conditions among geriatric condition
5.1.2. Restraints
5.1.2.1. Stringent and time-consuming regulatory approval process
5.1.3. Opportunities
5.1.3.1. Emerging investment in personalized medicine, and rising application in telemedicine
5.1.3.2. Notable shift towards natural and organic ingredients in dermatological products
5.1.4. Challenges
5.1.4.1. High treatment costs and stringent regulatory policy
5.2. Market Segmentation Analysis
5.2.1. Therapeutic Class: Proliferation of immunosuppressants in dermatology for the treatment of severe or refractory skin conditions
5.2.2. End-User: High inclination towards aesthetic and dermatology clinics owing to increasing societal emphasis on appearance and wellness
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Dermatology Drugs Market, by Therapeutic Class
6.1. Introduction
6.2. Antifungals
6.3. Corticosteroids
6.4. Immunosuppressants
6.5. Retinoids
7. Dermatology Drugs Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral Injection
7.4. Topical
8. Dermatology Drugs Market, by Indication Type
8.1. Introduction
8.2. Acne
8.3. Atopic dermatitis
8.4. Psoriasis
8.5. Skin cancer
9. Dermatology Drugs Market, by End-User
9.1. Introduction
9.2. Aesthetic & Dermatology Clinics
9.3. Diagnostic Centers & Laboratories
9.4. Hospitals
10. Dermatology Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital pharmacies
10.3. Retail pharmacies
11. Americas Dermatology Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Dermatology Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Dermatology Drugs Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Almirall and Microsoft announce partnership for the development of novel treatments for skin diseases
14.3.2. FDA Approves Arcutis’ ZORYVE (roflumilast) Topical Foam, 0.3% for the Treatment of Seborrheic Dermatitis
14.3.3. Eli Lilly forays into dermatological space with launch of psoriasis drug
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. DERMATOLOGY DRUGS MARKET RESEARCH PROCESS
FIGURE 2. DERMATOLOGY DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DERMATOLOGY DRUGS MARKET DYNAMICS
FIGURE 7. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. DERMATOLOGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. DERMATOLOGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DERMATOLOGY DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PARENTERAL INJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PARENTERAL INJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ACNE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ACNE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SKIN CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 82. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 83. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 84. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 85. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 86. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 87. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 90. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 91. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 92. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 93. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 94. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 95. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 96. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 97. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 100. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 135. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 136. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 137. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 138. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 139. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 140. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 141. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 144. CHINA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 145. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 146. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 147. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 148. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 149. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 150. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 151. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 154. INDIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 166. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 167. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 168. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 169. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 170. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 171. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 174. JAPAN DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 226. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 227. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 228. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 229. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 230. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 231. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 234. THAILAND DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 257. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 258. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 259. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 260. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 261. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 262. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 263. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 266. DENMARK DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 267. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 268. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 269. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 270. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 271. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 272. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 273. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 276. EGYPT DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 277. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 278. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 279. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 280. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 281. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 282. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 283. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 286. FINLAND DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 287. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 288. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 289. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 290. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 291. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 292. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 293. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 298. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 299. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 300. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 301. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 302. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 303. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 306. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 317. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 318. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 319. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 320. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 321. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 322. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 323. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 324. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 325. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 326. ITALY DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 327. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 328. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION TYPE, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 337. NIGERIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2023 (USD MILLION)
TABLE 338. NIGERIA DERMATOLOGY DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 20

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allergan plc by Abbvie Inc.
  • Almirall S.A.
  • Amgen Inc.
  • Arcutis Biotherapeutics, Inc.
  • Asterisk Laboratories
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Concert Pharmaceuticals by Sun Pharmaceutical Industries Limited
  • DermBiont, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Galderma S.A.
  • GlaxoSmithkline plc
  • Johnson & Johnson Services, Inc.
  • Leo Pharma A/S
  • Lupin Ltd
  • Mayne Pharma Group Ltd
  • Merck & Co., Inc
  • Novartis AG
  • Pfizer Inc.
  • Roivant Sciences Ltd.
  • Shinom Cosmeceuticals

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 34.23 Billion
Forecasted Market Value ( USD ) by 2030 $ 60.56 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal

Related Topics

Related Reports

Global Dermatology Drugs Market Analysis & Forecast 2024-2034: Market By Application; By Route Of Administration; By Distribution Channel; and By Region - Product Image

Global Dermatology Drugs Market Analysis & Forecast 2024-2034: Market By Application; By Route Of Administration; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Global Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Image

Global Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • 247 Pages
  • Global
From
Pediatric Dermatology Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032 - Product Image

Pediatric Dermatology Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

  • Report
  • 115 Pages
  • Global
From
Dermatology OTC Medications Global Market Report 2024 - Product Image

Dermatology OTC Medications Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Pigmentation Disorders Treatment Market by Indication (Hyperpigmentation, Hypopigmentation), Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing), End User - Forecast 2024-2030 - Product Image

Global Pigmentation Disorders Treatment Market by Indication (Hyperpigmentation, Hypopigmentation), Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing), End User - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From

About the Dermatological Drugs Market

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.